Autonomous continuous processing transforms API manufacturing with inline NMR, AI-driven control, and real-time optimization ...

Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy ...

In an industry where product quality increasingly determines competitive advantage, the ability to see what you're processing ...

NEWARK, Del., March 23, 2026--(BUSINESS WIRE)--Wilmington PharmaTech ("Wilmington"), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex custom ...

Wilmington PharmaTech, a CRDMO specializing in complex, custom active pharmaceutical ingredients (APIs) for small molecules, will drop $50 million to double its current production capacity at its ...

Axplora, a German CDMO that specializes in specialty active pharmaceutical ingredients for small molecules and antibody-drug conjugates, will shell out $60 million to expand its Farmabios ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Ireland is attracting major investment from the largest pharma companies in the world. Ben Hargreaves finds out how the country has become one of the most significant locations in Europe for ...

AtroPIM connects your product data directly to Amazon, now with A+ Content support, so your listings stay accurate, ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Most hydrogenation projects begin with a familiar mandate: a promising Business Case, challenging timelines, and a facility ...